Morgan Stanley Reiterates Overweight on SYK

Morgan Stanley has issued a report maintaining an Overweight Rating on Stryker Corporation SYK. According to the report, "In total, SYK reported an in-line quarter and maintained guidance, and our thesis remains intact. Gross margins, MedSurg performance and to a lesser extent taxes warrant further discussion." SYK has a $68 Price Target and closed at $59.16 a share yesterday.